arrow_back Back to App

Increased Brain Aneurysm Research Funding: Ellie's Law

Ellie's Law boosts funding for research into unruptured brain aneurysms to better understand the condition and improve treatment methods. This aims to reduce the thousands of annual deaths and permanent neurological deficits, as well as lower healthcare costs for patients and the system.
Key points
Increased funding for brain aneurysm research: $10 million annually for fiscal years 2026-2030 allocated to the National Institute of Neurological Disorders and Stroke.
Better understanding of the condition: Research will include a broader patient population, diversified by age, sex, and race, to develop more effective diagnostic and treatment methods.
Potential health and financial benefits: Improved treatments could reduce the risk of aneurysm rupture, leading to fewer deaths, fewer permanent neurological deficits, and lower treatment costs for patients and their families.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1609
Sponsor: Sen. Blumenthal, Richard [D-CT]
Process start date: 2025-05-06
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Ellie’s Law

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1609.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-06.

What are the main provisions?

Key points include:

  • Increased funding for brain aneurysm research: $10 million annually for fiscal years 2026-2030 allocated to the National Institute of Neurological Disorders and Stroke.
  • Better understanding of the condition: Research will include a broader patient population, diversified by age, sex, and race, to develop more effective diagnostic and treatment methods.
  • Potential health and financial benefits: Improved treatments could reduce the risk of aneurysm rupture, leading to fewer deaths, fewer permanent neurological deficits, and lower treatment costs for patients and their families.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Blumenthal, Richard [D-CT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health